<DOC>
	<DOCNO>NCT00343551</DOCNO>
	<brief_summary>The purpose study investigate efficacy ( blood pressure lower effect ) safety aliskiren give hypertensive patient miss dose .</brief_summary>
	<brief_title>Efficacy Safety Aliskiren 300mg Compared Irbesartan 300mg Ramipril 10 mg Setting Missed Dose Patients With Essential Hypertension .</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>Irbesartan</mesh_term>
	<criteria>Outpatients 18 year age old . Patients must meet follow blood pressure criterion : At Visit 2 : Office Mean Sitting Diastolic Blood Pressure ≥ 90 mmHg &lt; 110 mmHg At Visit 3 : Office Mean Sitting Diastolic Blood Pressure ≥ 95 mmHg &lt; 110 mmHg application Ambulatory Blood Pressure Measurement device At Visit 3 : 24hr Mean Ambulatory Diastolic Blood Pressure ≥ 85 mmHg Patient must absolute difference ≤ 10 mmHg office Mean Sitting Diastolic Blood Pressure Visit 2 3 . Male female patient eligible . Female patient must either postmenopausal least one year , surgically sterile use effective contraceptive method oral contraceptive , barrier method spermicide intrauterine device . Reliable contraception maintain throughout study 7 day study drug discontinuation . Patients eligible able participate study , consent purpose nature investigation clearly explain ( write inform consent ) . Severe hypertension [ Office Mean Sitting Diastolic Blood Pressure ≥ 110 mmHg and/or office mean sit systolic blood pressure ( MSSBP ) ≥ 180 mmHg ] . Current diagnosis heart failure ( NYHA Class IIIV ) . History myocardial infarction , coronary bypass surgery , percutaneous coronary intervention ( PCI ) 12 month prior Visit 1 . Known suspected contraindication study medication , include history allergy ACEInhibitors ARBs . Upper arm circumference &gt; 42 cm . Third shift night worker . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Hypertension , ambulatory blood pressure , miss dose , aliskiren</keyword>
</DOC>